SMMT Summit Therapeutics PLC ADRs
Summit Therapeutics PLC is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:SUMM.
$5.39 -0.09 (-1.64%)
As of 04/13/2021 15:59:44 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
ADRsCategory3:
Small cap
GICS sector: Health Care
Industry: Biotechnology
Index country: United Kingdom
Country of incorporation: United Kingdom
IPO date: 03/04/2015
Outstanding shares: 82,916,189
Average volume: 134,326
Market cap: $454,380,716
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
CUSIP: 86627T108
ISIN: US86627T1088
Sedol: BMTVQS7
Valuation (See tab for details)
PE ratio: -8.84
PB ratio: 5.70
PS ratio: 458.08
Return on equity: -66.18%
Net income %: -5,300.84%